Table 1.
Female gender | 116 (49.4) |
Caucasian race | 212 (90.2), unknown n = 12 |
Education, years | 13.9±2.4, unknown n = 4 |
Family history of neurological illness | 60 (26), adopted n = 5 |
Age at onset, years | 34.7±7.9 |
Age at presentation, years | 36.7±7.8 |
Years from onset to presentation | 2.0±2.2 |
Short test of mental status score at presentation (maximum 38) | 26.4±8.1 (n = 155, range 3–38), unable n = 48, not recorded n = 32 |
Onset of cognitive decline | |
Gradual | 181 (77.0) |
Subacute | 47 (20.0) |
Acute | 7 (3.0) |
Course of cognitive decline | |
Progressive | 217 (92.3), rapid n = 22 (9.4) |
Relapsing-progressive | 14 (6.0) |
Relapsing-remitting | 4 (1.7) |
Etiologies | |
Neurodegenerative | 73 (31) |
Autoimmune/inflammatory | 50 (21) |
Vascular | 14 (6) |
Metabolic | 25 (11) |
Infectious | 11 (5) |
Other | 18 (8) |
Unknown | 44 (19) |
Figures in parentheses are percentages.